-
Signature
-
/s/ Kristie Scott, Attorney-in-Fact
-
Issuer symbol
-
XMTR
-
Transactions as of
-
10 Nov 2025
-
Net transactions value
-
-$55,705
-
Form type
-
4
-
Filing time
-
12 Nov 2025, 16:38:49 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rollins Emily |
Director |
C/O XOMETRY, INC., 6116 EXECUTIVE BLVD, SUITE 800, NORTH BETHESDA |
/s/ Kristie Scott, Attorney-in-Fact |
12 Nov 2025 |
0001847014 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
XMTR |
Class A Common Stock |
Options Exercise |
$12,320 |
+1,000 |
+8.7% |
$12.32 |
12,455 |
10 Nov 2025 |
Direct |
F1 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$7,013 |
-106 |
-0.85% |
$66.16 |
12,349 |
10 Nov 2025 |
Direct |
F1, F2 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$12,492 |
-186 |
-1.5% |
$67.16 |
12,163 |
10 Nov 2025 |
Direct |
F1, F3 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$48,520 |
-708 |
-5.8% |
$68.53 |
11,455 |
10 Nov 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
XMTR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
+1,000 |
+286% |
$0.000000 |
1,350 |
10 Nov 2025 |
Class A Common Stock |
1,000 |
$12.32 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: